期刊
BIOMOLECULES
卷 11, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/biom11121903
关键词
ulcerative colitis; Crohn's disease; inflammatory bowel disease; intestinal microbiome; short chain fatty acids; dietary fibers
The increasing incidence of inflammatory bowel diseases necessitates new methods of therapy, with the gut microbiome being studied extensively as a key factor. The composition of intestinal microbiota can be modified by diet and probiotics, and enhanced by the use of paraprobiotics and postbiotics. This study summarizes recent works on various microbiome-altering methods in IBD.
The increasing incidence of inflammatory bowel diseases (IBD) and the increasing severity of the course of these diseases create the need for developing new methods of therapy. The gut microbiome is extensively studied as a factor influencing the development and course of IBD. The composition of intestinal microbiota can be relatively easily modified by diet (i.e., prebiotics, mainly dietary fibers) and bacterial supplementation using beneficial bacteria strains called probiotics. Additionally, the effects of the improved microbiome could be enhanced or gained by using paraprobiotics (non-viable, inactivated bacteria or their components) and/or postbiotics (products of bacterial metabolism or equal synthetic products that beneficially modulate immunological response and inflammation). This study summarizes the recent works on prebiotics, probiotics, synbiotics (products merging pre- and probiotics), paraprobiotics and postbiotics in IBD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据